San Francisco Bay Area biotech stories.
Wednesday, February 8, 2012
Velmedix gets $10.2M in Series B funds, adds CEO and VP
Velomedix said it has closed $10.2 million in Series B funding.
In addition, the Menlo Park-based development stage medical device company named Jeff Gold as CEO and Michael Moore and vice president of operations.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)